Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments.

× No keyword cloud information.

12 in total

Review 1. Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges.

Authors: M Odette Gore; Darren K McGuire; Ildiko Lingvay; Julio Rosenstock
Journal: Curr Cardiol Rep Date: 2015-07 Impact factor: 2.931

Review 2. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications.

Authors: C A Alvarez; I Lingvay; V Vuylsteke; R L Koffarnus; D K McGuire
Journal: Clin Pharmacol Ther Date: 2015-07-03 Impact factor: 6.875

Review 3. KATP channels and cardiovascular disease: suddenly a syndrome.

Authors: Colin G Nichols; Gautam K Singh; Dorothy K Grange
Journal: Circ Res Date: 2013-03-29 Impact factor: 17.367

Review 4. Adenosine Triphosphate-Sensitive Potassium Currents in Heart Disease and Cardioprotection.

Authors: Colin G Nichols
Journal: Card Electrophysiol Clin Date: 2016-03-19

Review 5. Should Metformin Remain First-Line Medical Therapy for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease? An Alternative Approach.

Authors: Josephine L Harrington; Natalia de Albuquerque Rocha; Kershaw V Patel; Subodh Verma; Darren K McGuire
Journal: Curr Diab Rep Date: 2018-07-14 Impact factor: 4.810

6. Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study.

Authors: Ulrik M Mogensen; Charlotte Andersson; Emil L Fosbøl; Tina K Schramm; Allan Vaag; Nikolai M Scheller; Christian Torp-Pedersen; Gunnar Gislason; Lars Køber
Journal: Diabetologia Date: 2014-09-10 Impact factor: 10.122

7. PATIENTS TREATED WITH INSULIN AND SULPHONYLUREA ARE AT INCREASED MORTALITY RISK AS COMPARED WITH THOSE TREATED WITH INSULIN PLUS METFORMIN.

Authors: S Ioacara; C Guja; O Georgescu; S Martin; A Sirbu; M Purcaru; S Fica
Journal: Acta Endocrinol (Buchar) Date: 2017 Jul-Sep Impact factor: 0.877

8. Comment on: Pantalone et al. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. Diabetes Care 2010;33:1224-1229.

Authors: Mykola D Khalangot
Journal: Diabetes Care Date: 2011-08 Impact factor: 19.112

Review 9. Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria.

Authors: P Iyngkaran; M Thomas
Journal: Clin Med Insights Cardiol Date: 2015-08-05

Review 10. Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus.

Authors: Shaveta Kaushal; Harmanjit Singh; Pugazhenthan Thangaraju; Jasbir Singh
Journal: N Am J Med Sci Date: 2014-03